SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
An ancient structure uncovered on the eastern slope of the City of David inside Jerusalem Walls National Park is believed to have been used for ritual practices during the time of the First Temple, ...
SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Long working hours might not just be bad for you, they could also be altering the structure of your brain, a new study suggests. The research was conducted by two scientists at South Korea’s Chung-Ang ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
The increased awareness of neurodiversity has led to the acceptance of a broad spectrum of 'normal' neurodevelopmental phenotypes. A new study in JCCP Advances develops a factor structure to examine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback